Variant report
Variant | esv32827 |
---|---|
Chromosome Location | chr6:34694806-34700121 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:34694281..34696402-chr6:34696757..34699128,2 | K562 | blood: | |
2 | chr6:34685141..34687022-chr6:34692903..34695560,2 | K562 | blood: | |
3 | chr6:34696691..34699544-chr6:34703628..34706154,2 | K562 | blood: | |
4 | chr6:34689130..34691156-chr6:34693829..34696616,2 | K562 | blood: | |
5 | chr6:34698371..34700265-chr6:34702057..34704593,2 | K562 | blood: | |
6 | chr6:34685141..34688900-chr6:34692903..34695756,4 | K562 | blood: | |
7 | chr6:34683902..34686435-chr6:34695998..34698813,2 | K562 | blood: | |
8 | chr6:34694281..34696402-chr6:34696757..34699128,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141264197 | chr6:34694857-34694858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565431747 | chr6:34694975-34694976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532620735 | chr6:34694976-34694977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188934022 | chr6:34695010-34695011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565675767 | chr6:34695021-34695022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79482832 | chr6:34695050-34695051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2814951 | chr6:34695081-34695082 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs144964348 | chr6:34695093-34695094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529207585 | chr6:34695116-34695117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79555446 | chr6:34695148-34695149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57916801 | chr6:34695221-34695222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs193249478 | chr6:34695281-34695282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146888527 | chr6:34695291-34695292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34116389 | chr6:34695365-34695366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554223452 | chr6:34695417-34695418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572475345 | chr6:34695432-34695433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536237087 | chr6:34695444-34695445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559620396 | chr6:34695459-34695460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34463942 | chr6:34695493-34695494 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs35444671 | chr6:34695505-34695506 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs543682838 | chr6:34695506-34695507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565456783 | chr6:34695521-34695522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182673112 | chr6:34695559-34695560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541293713 | chr6:34695581-34695582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559393614 | chr6:34695627-34695628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529853200 | chr6:34695630-34695631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527640179 | chr6:34695634-34695635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548314094 | chr6:34695638-34695639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs57037937 | chr6:34695689-34695690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563225776 | chr6:34695723-34695724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530541552 | chr6:34695871-34695872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148127266 | chr6:34695905-34695906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376984975 | chr6:34695909-34695910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112061163 | chr6:34695930-34695931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79016487 | chr6:34695959-34695960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534794554 | chr6:34696012-34696013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556889040 | chr6:34696031-34696032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs71000088 | chr6:34696060-34696061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141941652 | chr6:34696083-34696084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368628149 | chr6:34696118-34696119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547820312 | chr6:34696125-34696126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576777559 | chr6:34696137-34696138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71567461 | chr6:34696144-34696145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536301534 | chr6:34696160-34696161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs72910167 | chr6:34696165-34696166 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs373437059 | chr6:34696216-34696217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575996121 | chr6:34696218-34696219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12202688 | chr6:34696225-34696226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs71567462 | chr6:34696236-34696237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537083452 | chr6:34696292-34696293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:34694600-34696000 | Enhancers | K562 | blood |
2 | chr6:34696000-34699000 | Weak transcription | K562 | blood |
3 | chr6:34696400-34699400 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr6:34696400-34700600 | Enhancers | HepG2 | liver |
5 | chr6:34697200-34699200 | Enhancers | Fetal Muscle Trunk | muscle |
6 | chr6:34697400-34698200 | Enhancers | Fetal Heart | heart |
7 | chr6:34697400-34698200 | Enhancers | HSMM | muscle |
8 | chr6:34697400-34698200 | Enhancers | HSMMtube | muscle |
9 | chr6:34697600-34698200 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr6:34697600-34698200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr6:34697800-34698000 | Enhancers | Esophagus | oesophagus |
12 | chr6:34697800-34698200 | Enhancers | Left Ventricle | heart |
13 | chr6:34697800-34698200 | Enhancers | Psoas Muscle | Psoas |
14 | chr6:34698000-34714000 | Weak transcription | Esophagus | oesophagus |
15 | chr6:34698200-34698400 | Enhancers | Stomach Mucosa | stomach |
16 | chr6:34698400-34699000 | Weak transcription | Stomach Mucosa | stomach |
17 | chr6:34699000-34699400 | Enhancers | K562 | blood |
18 | chr6:34699000-34699800 | Enhancers | Stomach Mucosa | stomach |
19 | chr6:34699200-34700000 | Enhancers | Liver | Liver |
20 | chr6:34699400-34707000 | Weak transcription | K562 | blood |
21 | chr6:34699800-34712200 | Weak transcription | Stomach Mucosa | stomach |